TotalMarketCap

OKYO Pharma

OKYONasdaq GuernseyHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$73.471 M

$1.40 -2.10%

Close of 6 Nov 2026

As of 6 Nov 2026, OKYO Pharma (OKYO) has a market capitalization of $73.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

52,479,527

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #115Neumora TherapeuticsNMRA$92.4M
  2. #116Atara BiotherapeuticsATRA$80.7M
  3. #117OKYO PharmaOKYO$73.5M
  4. #118Tenaya TherapeuticsTNYA$72.6M
  5. #119Champions OncologyCSBR$66.7M

What if OKYO Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$538,055.04

Per share 384,325× higher

Bitcoin $1.53T

$29,113.22

Per share 20,795× higher

Apple $5.02T

$95,575.99

Per share 68,269× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for OKYO Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.